Welcome to Medisoft Pharma – your trusted partner for health and personal care needs - Shop Now

Need Help?

+91-9816557529

KOJISOFT CREAM

Kojic Acid-5%,Niacinamide-5%,Vit. E-1%, Liquorice Ext-2%, A-Arbutin-1.5%Mulberry Ext- 1%, Octinoxate-7.5% & Glycolic Acid-3% CREAM

269.00 242.10
Quantity
Unleash Radiant Skin with Kojisoft Cream

Kojisoft Cream is an amalgamation of natural extracts and the modern science of skin care to brighten, nurture and protect skin. It was to be used on uneven color, dark spots, and pigmentation caused by the sun; it was suitable by a man or a woman alike. Its non-toxic, mild formula rehydrates the skin and increases its clarity, and skin is left soft, smooth and refreshed. Regular use encourages the healthy skin to match in tone, glow, and refreshed look, of someone young and sunlit and pleased with noticeable enhancement of results with time period.

Active Ingredients and Their Role

The 5% Kojic Acid and the likeness is added with 5% Niacinamide, which make the skin pigmented and lightened. Liquorice Extract (2%), Mulberry Extract (1%), and A-Arbutin (1.5) combination are all aimed at reducing dark spots and uneven tone. The components of Octinoxate (7.5%) is UV protection, Glycolic Acid (3) serves as a skin exfoliator, and Vitamin E (1) is a skin nurture. This combination improves the texture, houses the moisture and soft healthy and radiant skin. It helps in the day to day care and helps in resisting any stressor in the environment.

Visible Benefits and Results

Kojisoft Cream decreases dark dots, sun tan, and discoloration, smoothes the skin and makes it soft with regular use. The skin turns lighter, flawless, and necessarily radiant. Hydration and elasticity are enhanced and balance restored on the daily usage. Skin looks revitalized, renewed and not worn down. In the long term, the product improves health complexity of the skin making everyone look confident and full of youthful appearance, making it necessary to incorporate the product in the daily skincare practices of both genders.

2
3